Anti-Xa activity : low molecular weight heparin - LMWH - plasma
Back to main menuEurofins Biomnis code
XA
Synonyms
- Measurement of anti-Xa activity - low molecular weight heparin
- Anti-Xa - LMWH
- Anti-Xa activity - low molecular weight heparin
Clinic significance
Heparin is prescribed to prevent or correct thrombosis and embolization. For low molecular weight heparin therapy, the sample should be taken 3 to 4 hours after injection.
Prenalytics
- 1 mL
- Citrated Plasma
- FROZEN
Further information
- Sample 3 to 4 hours after subcutaneous injection of Lovenox®, Fragmine®, Fraxiparine® , Clivarine® or 4 to 6 hours after subcutaneous injection of Innohep® or Fraxodi®
- ALWAYS specify the current anticoagulant treatment (dosage) and the injection and sampling times
- It is advisable to send us a frozen and centrifuged citrate sample in compliance with the GFHT pre-analytical recommendations.
- Sample to be frozen within 1 hour. Home sampling is not advisable.
- Enclose the specific clinical information form (R5-INTGB : Haemostasis)
Documents to download
Methodology
Chromogenic method
Turnaround time
2 days
Pathologist(s) in charge
Biomnis Paris
Specialty
Haematology
Contact(s)
Dr Léna LE FLEM
Dr Dominique ENGERAND
Dr Laurence GUIS
Dr Dominique ENGERAND
Dr Laurence GUIS
E-mail(s)
Phone(s)
+331 49 59 17 44
+331 49 59 62 70
+331 49 59 15 01
+331 49 59 62 70
+331 49 59 15 01
